Linda C Giudice

No ORCID on file · 175 papers in corpus · active 1986-2026

Study types

  • article 111
  • review 29
  • book-chapter 11
  • other 10
  • preprint 5

Condition tags

  • endometriosis 148
  • mesh:D004715 78
  • infertility 47
  • dysmenorrhea 14
  • adenomyosis 12
  • mesh:D017699 9
  • chronic_pelvic_pain 7
  • mesh:D004412 7
  • dyspareunia 5
  • mesh:D004414 4
review 2026
Current opinion in obstetrics & gynecology ·doi:10.1097/GCO.0000000000001099

PURPOSE OF REVIEW: Progesterone plays a pivotal role in implantation and ongoing pregnancy. In the context of assisted reproductive technology (ART), and in particular frozen embryo transfer (FET), increasing evidence suggests that serum pr…

other 2025
Cell reports methods ·doi:10.1016/j.crmeth.2025.101137

High-throughput sequencing enables efficient processing of DNA and RNA samples in batches, but batch effects can obscure true biological signal. We propose using anticlustering as an automated method to assign samples to balanced batches, m…

other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.05.28.656743

INTRODUCTION AND METHODS: Endometriosis has limited treatment options, prompting the search for novel therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline to analyze public bulk transcriptomic d…

article 2025
·doi:10.1016/j.lanogw.2025.100004
other 2025
medRxiv : the preprint server for health sciences ·doi:10.1101/2025.02.13.25322244

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterog…

other 2025
Cell reports. Medicine ·doi:10.1016/j.xcrm.2025.102245

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterog…

review 2025
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2024.08.043
preprint 2025
·doi:10.21203/rs.3.rs-7377239/v1
article 2025
·doi:10.1016/j.lanogw.2025.100027
article 2025
International journal of molecular sciences ·doi:10.3390/ijms26083760

Endometriosis is a chronic gynaecological disease characterised by endometrial-like tissue found external to the uterus. While several studies have reported strong evidence of a genetic contribution to the disease, studies on the environmen…

article 2025
·doi:10.1016/s3050-5038(25)00113-x
review 2025
npj women's health ·doi:10.1038/s44294-024-00052-w

Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgica…

article 2025
·doi:10.1016/j.fertnstert.2025.07.320
other 2025
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2025.12.047
article 2024
·doi:10.1097/grh.0000000000000074

Endometriosis is a common, underdiagnosed, systemic inflammatory, and endocrine pain disorder that impacts the quality of life of millions of persons with a uterus globally. It is associated with chronic pelvic pain and an increased risk of…

other 2024
iScience ·doi:10.1016/j.isci.2024.109388

Existing medical treatments for endometriosis-related pain are often ineffective, underscoring the need for new therapeutic strategies. In this study, we applied a computational drug repurposing pipeline to stratified and unstratified disea…

review 2024
Radiology ·doi:10.1148/radiol.233482

Endometriosis is a common condition impacting approximately 190 million individuals and up to 50% of women with infertility globally. The disease is characterized by endometrial-like tissue located outside of the uterine corpus, which cause…

article 2024
Human Reproduction ·doi:10.1093/humrep/dead263

STUDY QUESTION: What is the efficacy and safety of long-term treatment (up to 2 years) with relugolix combination therapy (CT) in women with moderate to severe endometriosis-associated pain? SUMMARY ANSWER: For up to 2 years, treatment with…

article 2023
·doi:10.1016/j.jmig.2023.08.392
article 2023
Pain management ·doi:10.2217/pmt-2023-0052

WHAT IS THIS SUMMARY ABOUT?: This is a summary of research studies (known as clinical trials) called SPIRIT 1 and SPIRIT 2. The SPIRIT 1 and SPIRIT 2 studies compared how well a medicine called relugolix combination therapy worked in reliev…

other 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.04.021

OBJECTIVE: To determine whether B-cell lymphoma 6 (BCL6), an endometriosis-associated marker postulated to predict poor pregnancy outcomes, is differentially expressed in the window of implantation with various uterine preparation regimens …

article 2023
·doi:10.1097/01.aog.0000929844.43483.20

INTRODUCTION: Relugolix combination therapy (Relugolix-CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) significantly improved endometriosis-associated pain versus placebo in the SPIRIT 1&2 studies. Efficacy was maintained…

article 2023
·doi:10.1016/j.fertnstert.2023.08.204
review 2023
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.202300907

Endometriosis is a common estrogen-dependent disorder wherein uterine lining tissue (endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infertility. Recent evi…

book-chapter 2023
·doi:10.1016/b978-0-323-91380-5.00018-6